Clinical Trials
1
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Impact of Uterine Immune Profiling and Personalized Treatments in Patients Receiving a Single Blastocyst: a Matched Controlled Study
Not yet recruiting
- Conditions
- InfertilitySuccess Rate of Assisted Reproductive TherapySingle Embryo TransferPregnancy OutcomesImmunological ToleranceImmune System
- First Posted Date
- 2024-07-16
- Last Posted Date
- 2024-12-27
- Lead Sponsor
- Matricelab Innove
- Target Recruit Count
- 340
- Registration Number
- NCT06503952
- Locations
- 🇫🇷
Hopital des diaconnesse- Centre d'assistance medicale a la procreation, Paris, ile de France, France
🇫🇷Hopital des Bluets- centre d'assistance medicale à la procreation, Paris, Ile de, France
News
Breakthrough Study: Endometrial Immune Profiling Boosts IVF Success Rates by 40%
A landmark randomized controlled trial by MatriceLab Innove demonstrates that personalized treatment based on endometrial immune profiling increases IVF live birth rates from 29.7% to 41.4%.